HISAMITSU PHARMACEUTICAL CO.,INC. (4530.T) Financial Statements

Income statement

Metric	TTM	2026	2025	2024	2023
Revenue
Total Revenue	163.0B	163.0B	156.0B	141.7B	128.3B
Cost of Revenue	13.4B	66.9B	64.8B	62.7B	55.6B
Gross Profit	21.3B	96.1B	91.2B	79.0B	72.7B
Operating Expenses
R&D Expense	—	—	—	—	—
SG&A Expense	17.9B	78.2B	72.3B	65.8B	61.1B
General & Admin Expense	—	—	—	—	—
Selling & Marketing Expense	—	—	—	—	—
Other Expenses	—	—	—	—	—
Total Operating Expenses	17.9B	78.2B	72.3B	65.8B	61.1B
Cost and Expenses	145.1B	145.1B	137.1B	128.5B	116.7B
Operating Income (EBIT)	17.9B	17.9B	18.9B	13.2B	11.6B
Non-Operating
Interest Income	498.0M	2.4B	2.7B	2.6B	894.0M
Interest Expense	2.0M	21.0M	23.0M	18.0M	15.0M
Net Interest Income	496.0M	2.3B	2.7B	2.5B	879.0M
Other Non-Op Income/Expense	415.0M	6.0B	5.1B	6.5B	4.5B
Non-Operating Income (excl Interest)	292.0M	3.8B	2.6B	4.0B	3.9B
EBT (Pre-Tax Income)	3.8B	23.7B	28.7B	19.2B	16.1B
Income Tax Expense	1.2B	4.1B	6.4B	4.8B	4.0B
Bottom Line
Net Income	19.2B	19.2B	21.8B	14.0B	11.7B
Earnings from Cont. Ops	—	—	—	—	—
Earnings from Discont. Ops	—	—	—	—	—
Bottom Line Net Income	19.2B	19.2B	21.8B	14.0B	11.7B
Per Share
Basic EPS	¥266	¥269	¥296	¥182	¥148
Diluted EPS	¥266	¥269	¥295	¥181	¥148
Revenue Per Share	¥2,285	¥2,285	¥2,119	¥1,842	¥1,617
Shares
Basic Shares Outstanding	71.3M	71.3M	73.6M	76.9M	79.3M
Diluted Shares Outstanding	—	—	—	—	—
Profitability Metrics
EBITDA	—	24.8B	25.1B	18.3B	16.6B
D&A	—	6.9B	6.2B	5.1B	5.0B
EBIT	17.9B	17.9B	18.9B	13.2B	11.6B

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Feb 1, 2026